Sen. Rick Scott is turning up the heat on federal health regulators, demanding a broad investigation into how Chinese entities are involved in U.S. clinical trials. The Florida Republican argues that ...
FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the supplemental application for nivolumab plus AVD. SWOG S1826 showed superior ...
An informational report compiling GaraHerb's publicly available product materials, ingredient-level research references, formulation transparency considerations, and consumer details for 2026 ...
An informational summary of how the Akusoli Fat Burner Metabolism Bundle is described in publicly available company materials, including ingredient labeling, insole positioning, and consumer policy di ...
Opinion
14hOpinion
Christine Ledbetter: A Northwestern waiting room fills with cancer patients while federal cuts reverse progress
The Trump regime has proposed eliminating cancer screening and prevention programs and has cut billions in funds.
16h
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any time and a durable 76% CR rate at 12 months, with favorabl ...
Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025?Affected Soleno Therapeutics, Inc. Investor ...
RESEDA, CA - March 20, 2026 - PRESSADVANTAGE - Moment of Clarity has released a detailed educational resource outlining ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
Medicare has implemented a new pilot program that requires preapproval for many treatments. The pilot program is currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results